• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Armetheon - Articles and news items

1000 patient Phase III study required for Armetheon before FDA approval

Industry news / 10 February 2017 / Niamh Marriott, Digital Editor

Armetheon has reached agreement with the FDA for a single 1000 patient final pivotal trial for its drug candidate, tecarfarin, prior to filing an NDA…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +